Literature DB >> 17328053

Setting priorities for research: a practical application of 'payback' and expected value of information.

Rachael L Fleurence1.   

Abstract

BACKGROUND: Setting priorities for research using economic in addition to scientific criteria can ensure that resources are spent efficiently and equitably.
OBJECTIVE: This study applies two priority setting methods 'payback' and expected value of information (EVI) to two research areas (osteoporosis and pressure ulcers) and where appropriate to four clinical trials: the Record Trial, the Vitamin D and Calcium Trial and the Hip Protector Trial (osteoporosis), and the Pressure Trial (wound care).
METHODS: Two decision-analytic models were developed. For 'payback', the PATHS model was used to estimate the expected net benefits of conducting the four clinical trials. An EVI framework was applied to estimate the cost-effectiveness of conducting further research in the two disease areas investigated.
RESULTS: The application of 'payback' suggests that the Record Trial and the Vitamin D and Calcium Trial would be cost-effective. The Hip Protector and the Pressure Ulcer Trial are cost-effective under certain assumptions concerning the likelihood of obtaining positive, negative or inconclusive results. The EVI method suggests that research would be potentially cost-effective in these areas in the populations considered.
CONCLUSION: EVI provides strategic information for setting priorities for research between disease areas and study populations. 'Payback' provides information on the cost-effectiveness of specific research designs. However, further work in this area, particularly concerning the issue of implementation of research, is required. Copyright (c) 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17328053     DOI: 10.1002/hec.1225

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  7 in total

Review 1.  A systematic and critical review of the evolving methods and applications of value of information in academia and practice.

Authors:  Lotte Steuten; Gijs van de Wetering; Karin Groothuis-Oudshoorn; Valesca Retèl
Journal:  Pharmacoeconomics       Date:  2013-01       Impact factor: 4.981

2.  Systematic review of methods for evaluating healthcare research economic impact.

Authors:  Bahareh Yazdizadeh; Reza Majdzadeh; Hojat Salmasian
Journal:  Health Res Policy Syst       Date:  2010-03-02

3.  Conceptual frameworks and empirical approaches used to assess the impact of health research: an overview of reviews.

Authors:  Rita Banzi; Lorenzo Moja; Vanna Pistotti; Andrea Facchini; Alessandro Liberati
Journal:  Health Res Policy Syst       Date:  2011-06-24

4.  Quantitative benefit-harm assessment for setting research priorities: the example of roflumilast for patients with COPD.

Authors:  Milo A Puhan; Tsung Yu; Cynthia M Boyd; Gerben Ter Riet
Journal:  BMC Med       Date:  2015-07-02       Impact factor: 8.775

Review 5.  Chronic rhinosinusitis: an under-researched epidemic.

Authors:  Luke Rudmik
Journal:  J Otolaryngol Head Neck Surg       Date:  2015-03-05

6.  Post-acute pathways among hip fracture patients: a system-level analysis.

Authors:  Kristen B Pitzul; Walter P Wodchis; Michael W Carter; Hans J Kreder; Jennifer Voth; Susan B Jaglal
Journal:  BMC Health Serv Res       Date:  2016-07-18       Impact factor: 2.655

7.  Research prioritization of men's health and urologic diseases.

Authors:  Tyler Okland; Chante Karimkhani; Hannah Pederson; Lindsay N Boyers; Mark D Sawyer; Kyle O Rove; McCabe C Kenny; Steven Steinberg; Mohsen Naghavi; Robert P Dellavalle
Journal:  Int Braz J Urol       Date:  2017 Mar-Apr       Impact factor: 1.541

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.